Ohio State Wexner Medical Center wins $14 million award for aspirin dose study

A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.

Lack of in-person contact is main HCP concern

Concerns have arisen that AI could have a damaging effect on the doctor-physician relationship. Credit: Blue Planet Studio via Shutterstock. Physicians play a crucial role

October 18, 2023

Researchers identify protein linked to cardiovascular health in progeria

A new University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with

October 18, 2024

Nuvectis receives orphan drug for cholangiocarcinoma therapy

Cholangiocarcinoma accounts for approximately 3% of all gastrointestinal malignancies. Credit: Explode / Shutterstock.com. Nuvectis Pharma has received orphan drug designation from the US Food and

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.